Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Bensinger

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2009
Clinical and ultrasonic evaluation of spleen size during peripheral blood progenitor cell mobilization by filgrastim: results of an open-label trial in normal donorsPatrick J Stiff, William Bensinger, Muneer H Abidi, et al.
Leukemia|May 16, 2020
A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myelomaJoseph Mikhael, Joshua Richter, Ravi Vij, et al.
Blood|July 12, 2003
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myelomaDavid G Maloney, Arthur J Molina, Firoozeh Sahebi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 29, 2014
Lenalidomide maintenance for high-risk multiple myeloma after allogeneic hematopoietic cell transplantationMelissa Alsina, Pamela S Becker, Xiaobo Zhong, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 13, 2014
Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow TransplantationHien K Duong, Bipin N Savani, Ed Copelan, et al.
Blood|November 19, 2008
Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allograftingMarcello Rotta, Barry E Storer, Firoozeh Sahebi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2007
Multiple myeloma. Clinical practice guidelines in oncologyKenneth C Anderson, Melissa Alsina, William Bensinger, et al.
Ejhaem|July 18, 2022
Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myelomaCristina Gasparetto, Suzanne Lentzsch, Gary Schiller, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 3, 2009
NCCN clinical practice guidelines in oncology: multiple myelomaKenneth C Anderson, Melissa Alsina, William Bensinger, et al.
Blood|July 22, 2016
Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myelomaHervé Avet-Loiseau, Rafael Fonseca, David Siegel, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2009
Clinical and ultrasonic evaluation of spleen size during peripheral blood progenitor cell mobilization by filgrastim: results of an open-label trial in normal donorsPatrick J Stiff, William Bensinger, Muneer H Abidi, et al.
Leukemia|May 16, 2020
A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myelomaJoseph Mikhael, Joshua Richter, Ravi Vij, et al.
Blood|July 12, 2003
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myelomaDavid G Maloney, Arthur J Molina, Firoozeh Sahebi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 29, 2014
Lenalidomide maintenance for high-risk multiple myeloma after allogeneic hematopoietic cell transplantationMelissa Alsina, Pamela S Becker, Xiaobo Zhong, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 13, 2014
Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow TransplantationHien K Duong, Bipin N Savani, Ed Copelan, et al.
Blood|November 19, 2008
Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allograftingMarcello Rotta, Barry E Storer, Firoozeh Sahebi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2007
Multiple myeloma. Clinical practice guidelines in oncologyKenneth C Anderson, Melissa Alsina, William Bensinger, et al.
Ejhaem|July 18, 2022
Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myelomaCristina Gasparetto, Suzanne Lentzsch, Gary Schiller, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 3, 2009
NCCN clinical practice guidelines in oncology: multiple myelomaKenneth C Anderson, Melissa Alsina, William Bensinger, et al.
Blood|July 22, 2016
Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myelomaHervé Avet-Loiseau, Rafael Fonseca, David Siegel, et al.
Pageof 5